Nationwide Children's Gets Another Gene Therapy on FDA Fast-Track

Published October 23, 2013

Nationwide Children's gets another gene therapy on FDA fast-track
AveXis Inc., a Dallas company that was formed in July and licensed the therapy from the Columbus hospital, announced Thursday that it had received the OK for a sped-up approval process from the U.S. Food and Drug Administration. Brian Kaspar with the … Read more on Business First of Columbus

Abeona Therapeutics and Nationwide Children's Hospital Win Global Genes …
"My lab has focused on developing gene therapy approaches for efficient gene delivery to the central nervous system for the treatment of mucopolysacchradosis IIIB, or Sanfilippo Syndrome type B," explains Dr. Fu, who is an investigator in the Center … Read more on HispanicBusiness.com

Report: VA hospitals across nation prescribing more opiates than ever
An investigation by the Center for Investigative Reporting found physicians in the U.S. Department of Veterans Affairs increasingly were prescribing potent painkillers instead of more complex treatment for military personnel after the Sept. 11, 2001 … Read more on Mansfield News Journal